Minoxidil: how it works, what forms it comes in, and what its side effects are.
Minoxidil was originally a blood pressure medication; its hair-growth effect was discovered by accident. Here's the essence: how it works, solution or foam, side effects, what happens if you skip a dose or stop, and how it connects to microneedling. The exact usage is given on the product label, and if you experience a side effect, see a doctor.
What is minoxidil?
Minoxidil was originally developed for severe, hard-to-treat high blood pressure as a potent vasodilator drug. StatPearls A side effect showed up during use: some patients grew denser, stronger hair. This observation later led to the scalp-applied product used for hair loss. Suchonwanit 2019 This is a medication, not a cosmetic.
Minoxidil is meant for patterned (androgenetic) hair loss; for more on the pattern and other options: male and female hair loss. Sudden, diffuse shedding is a different situation: there, you look for the trigger, and minoxidil's effect isn't proven. Read about it here.
How does it work on hair?
The exact mechanism is still not fully understood. Minoxidil has a potassium-channel-opening and vasodilating effect, meaning it supports local blood flow. StatPearls On hair, the effect is exerted by minoxidil sulfate, the active form produced in the scalp by an enzyme (sulfotransferase). Suchonwanit 2019
The key point is in the hair's life cycle: minoxidil appears to lengthen the anagen, meaning the growth phase. Suchonwanit 2019 This keeps the hair in the growing state longer, and over time the hair can look denser and stronger. This effect was shown across groups of hair follicles in clinical trials.
Every hair follicle goes through this cycle: it grows in the anagen phase, for years; it retracts in the catagen phase; it rests in the telogen phase, then sheds, and the follicle restarts. Minoxidil intervenes here by making the anagen, the growth stage, longer. The exact molecular background is still an open question in research.
Solution or foam?
Scalp-applied minoxidil is available in both solution and foam form, in lower and higher concentrations. The main difference is in the carrier:
- Solution: contains alcohol and propylene glycol. Propylene glycol helps the active ingredient penetrate, but for many people this is exactly what irritates the scalp (itching, flaking, sometimes allergic contact dermatitis). Suchonwanit 2019
- Foam: made without propylene glycol, so it's typically gentler, absorbs quickly, and is less sticky. If the solution irritates you, foam is often the better choice.
| Solution | Foam | |
|---|---|---|
| Carrier | alcohol + propylene glycol | no propylene glycol |
| Tolerability | can irritate many people | typically gentler |
| Feel | propylene glycol aids penetration | absorbs quickly, less sticky |
| Who it's for | if you tolerate it well | if your scalp itches, flakes, or burns |
Minoxidil's side effects
Minoxidil is a real medication, with real side effects. The most common ones:
- Increased shedding at the start of treatment ("shedding"): minoxidil shortens the resting phase, and this switch can come with extra shedding. StatPearls It's a scary experience, but the phenomenon is a known part of treatment. If the shedding stays heavy, is patchy, or comes with a burning scalp, it's worth getting checked by a doctor.
- Scalp irritation: itching, flaking. Often caused by the carrier: the propylene glycol in the solution irritates many people's scalps, and can also trigger allergic contact dermatitis. Suchonwanit 2019 In that case, the propylene-glycol-free foam is typically gentler; if the foam irritates too, that may point to the active ingredient itself.
- Unwanted facial and body hair: the hair-growth effect doesn't stop at the scalp. The chance of it rises with higher concentration, and it's more common in women; according to the review, it typically recedes on its own within months after stopping, first on the face and arms, later on the legs. Suchonwanit 2019 It helps to apply it only to the scalp, wash your hands afterwards, and let it dry before you lie your head on a pillow.
- Systemic effects: the major systemic side effects (fluid retention, weight gain, blood pressure effects) belong to the oral form; for the topical form, the review found no systemic side effects at twice-daily use, and in the arms of one study in women a small proportion reported heart palpitations. Suchonwanit 2019 If you experience heart palpitations, swelling, or dizziness, stop and see a doctor. If you have existing heart or vascular disease, talk to a doctor before you even start.
And the thing many people fear, that actually belongs to a different drug: stories about sexual side effects are typically about finasteride. Minoxidil works through a different pathway: a potassium-channel-opening vasodilator StatPearls, not a 5-alpha-reductase inhibitor, so the hormonal side-effect profile described for finasteride doesn't carry over to it. You can read about finasteride's side-effect profile in the article on DHT blockers.
What if I skip a dose or stop?
Minoxidil's effect is maintenance-dependent. As long as you use it, your hair stays on the growth side; but the gain depends on regular use.
Missing a single dose isn't a tragedy. Whether you keep your hair isn't decided day by day, so if you miss a day now and then, that alone doesn't upset anything. Just continue as usual, there's no point making up for it with a double dose.
Stopping long-term is a different question. Long-term use is needed for the achieved state to be maintained, because the effect fades once you stop. StatPearls The hair gained typically sheds back gradually over the following months to where your hair would be without treatment. Suchonwanit 2019 That's why it's worth thinking through at the start whether you're committing to the long term. If you want to stop, you can do so at any time, just expect the gradual reversal.
Minoxidil can help many people, but it's a medication, not a cosmetic, and its effect depends on continuous use. It's up to you to decide whether to start; you choose the concentration and form based on the label and your own skin's tolerance.
Microneedling and minoxidil together
For hair, the strongest data is on the combination of microneedling and minoxidil. In an evaluator-blinded study, the group that also received microneedling grew meaningfully more new hair than those using minoxidil alone. Dhurat 2013
This study was done with a 1.5 mm clinical roller, one treatment a week, under controlled clinical conditions, over 12 weeks. Dhurat 2013 The Dermastamp is a fixed 1 mm, at-home device, and wasn't part of this study. The cited evidence is about the mechanism of microneedling: the needle stimulates the environment around the follicle.
Microneedling opens tiny channels in the scalp. The needle doesn't target the hair bulb itself, but the environment around the follicle: it stimulates local blood flow and growth factors. Cureus 2025 In theory this could also help minoxidil penetration and effect, but this hasn't been measured with the Dermastamp.
In the study protocol, minoxidil was not applied on the day of microneedling; application resumed only 24 hours after treatment. Dhurat 2013 It's not a good idea to apply an active ingredient to freshly punctured skin right away at home either.
The active ingredient penetrates more easily through fresh microchannels, so we don't apply minoxidil right away to freshly punctured, sensitive skin. Cureus 2025 The studied protocol skipped application on the day of puncturing, and resumed minoxidil only 24 hours after treatment. Dhurat 2013
You can read more about the exact timing and using the 1 mm Dermastamp here: stamp frequency and minoxidil timing, and the basics of microneedling. All of microneedling's documented risks and contraindications: risks and things to know. The exact minoxidil dosage is given on the product label.
Microneedling was measured together with minoxidil, and the group that also received microneedling grew more new hair. The study was done with a 1.5 mm clinical roller; the Dermastamp is a fixed 1 mm at-home device and wasn't measured in it. By mechanism it's the same stimulus, the needle stimulates the environment around the follicle, but this is inferred, not measured. You skip minoxidil on stamping day and resume it 24 hours later. What it does, what it doesn't, and who it isn't for: it's all written on its page.
The bleach test: what it shows, and what it doesn't. There's a home test that lives on in the community: you mix a little solution with a little household bleach, and if the mixture turns a yellowish-orange colour, it contains minoxidil. The logic is that bleach is a strong oxidizer, and according to reports it causes a colour change with minoxidil. I found no published, controlled validation of it, so this is a home signal, not a lab measurement.
What a positive result can prove: that the liquid contains an active ingredient that reacts with bleach. What it doesn't tell you: how much is in it, and what else is alongside it. Those are exactly the two questions with a counterfeit. On our hair-loss forum, moreover, experience runs both ways: one person had one bottle change colour and another not, with the same label, and there's also debate about how much the genuine product changes colour. A negative result is therefore a strong red flag, and a positive one is a reassuring sign, but not proof.
If you try it: work with a few drops, in a well-ventilated space, and don't mix the bleach with another cleaning product, since it's a corrosive substance, and mixed with acid it can release chlorine gas. Pour out the tested amount afterwards.
On forums it's seen as the "more serious version," the one people switch to when the solution isn't enough. The trials say something different.
In the largest, double-blind trial, one tablet a day went up against the twice-daily 5% solution, over 24 weeks, and according to the closing statement, oral minoxidil "did not demonstrate superiority" JAMA Dermatology, 2024. In an analysis pooling four trials and 279 participants (which includes the trial above), there was likewise no measurable difference in hair density and hair-shaft thickness; there was one exception, unwanted hair growth was twice as common with the oral form Int J Dermatol, 2025. The limitation: "we found no difference" is not the same as "proven equivalent." What can be said is that the big advantage mentioned on forums didn't show up in these trials.
According to a pooled analysis of six trials, every +1 mg daily dose increase was associated with an average of +47.1 more hairs per square centimeter over half a year, but the same increase also came with a +17.9% unwanted-hair-growth risk and a +4.8% circulatory side-effect risk Skin Appendage Disord, 2022. More hair and more side effects are two sides of the same dose, you can't ask for just one. The limitation: this analysis compares data across six trials, so it shows an association, not proof of causation. Dosing is the prescribing doctor's job, who knows your blood pressure, your heart, and what you can tolerate.
Two things not to do. Don't drink the topical solution: the 5% solution contains 50 mg of minoxidil per millilitre, many times the tablet dose used for hair loss, and in 2024 the European medicines authority made it mandatory to add "Do not ingest." to the box, because of the data available on accidental ingestion EMA/CMDh, 2024. And don't order from an unlabeled source: by definition there's no manufacturer quality assurance and no regulatory oversight there, so you don't know how much active ingredient is in it or what else is in it.
Finally, something that goes against our own interest. This site is run by a company that sells a microneedling device, so you might expect me to tie the two together: there's no study on the combined effect of oral minoxidil and microneedling. We searched two major scientific databases and found not a single one that measured the two together search details at the source. And the existing data shouldn't be carried over to the tablet: the most-cited microneedling study was done with topical minoxidil, where needling may help, in part, precisely by opening a path for the active ingredient applied to the surface. With a tablet, the active ingredient arrives from the bloodstream, so this explanation loses its meaning.
The tablet in summary: in the trials it did not outperform the topical form, but unwanted hair growth is more common with it. In exchange, there's no daily rubbing-in and nothing gets on the pillow. It requires a prescription, and the authority has given dermatology specialists a simplified procedure for prescribing it.
Frequently asked questions
How long does it take for minoxidil to work?
It takes patience: hair growth is a slow process, for many people it's half a year or more before a difference is visible, and for some it doesn't bring meaningful change. You decide whether to continue based on the effect you see.
Is it normal that I lose more hair at the start? (the "dread shed")
The initial increased shedding is often called the "dread shed." According to reports, it's common and typically temporary: some hairs move into the resting phase faster so a new hair can start, and the shedding typically settles back within a few weeks. If the shedding stays heavy, persistent, or patchy, though, it's worth getting checked by a doctor, since a different cause could be behind it.
Is solution or foam better?
If you tolerate it well, the solution works fine too. If it makes your scalp itch, flake, or burn, foam is often gentler because it's made without propylene glycol. You choose the concentration and form based on your skin's tolerance.
What concentration do I need, higher or lower?
Scalp-applied minoxidil is available in both lower and higher concentrations; the higher, five-percent solution is the most commonly used, while many people tolerate the lower concentration better, and for women the lower concentration or the foam is often the go-to choice (female pattern hair loss has its own article: female hair loss). Higher concentration also increases the chance of unwanted hair growth and irritation. Suchonwanit 2019 Which one is right for you depends on your skin's tolerance and your goal.
Is there an oral (tablet) form of minoxidil too?
Yes, there's also a low-dose oral form of minoxidil, which is increasingly mentioned for hair loss, but this is off-label use outside its official indication, and it requires medical supervision. StatPearls Systemic effects, such as heart palpitations, a fast pulse, or fluid retention, are more common with the oral form, so a doctor needs to weigh the cardiovascular considerations. Don't confuse it with the scalp-applied form, since the dosing and the risk profile are different. Be sure to discuss this with your treating doctor.
What happens if I skip a day or two?
Missing a dose here and there isn't a big deal on its own. The effect depends on regular use, but whether you keep your hair isn't decided day by day. If you miss a day now and then, just continue as usual, there's no need to make up for it with a double dose. What matters is long-term consistency.
And if I stop for weeks or for good? Will the hair fall out again?
Minoxidil's effect depends on maintenance. After stopping, the hair gained typically sheds back gradually over the following months to where your hair would be without treatment. Suchonwanit 2019 It doesn't happen suddenly, but slowly. That's why it's worth thinking through at the start whether you're committing to the long term. If you want to stop, you can do so at any time, just expect the gradual reversal.
Once I start, can I stop? Do I have to keep going forever?
Maintaining the effect requires continuous use, essentially for as long as you want the result. After stopping, the gain can slowly reverse over the following months. That's why it's worth thinking through at the start whether you're committing to the long term.
Can women use it too?
Yes, women use it too, typically the lower concentration or the foam, because the higher concentration more often causes unwanted hair growth in women. Suchonwanit 2019 Pregnancy and breastfeeding are a separate question: ask a doctor in that case.
Can I use it together with finasteride?
Many people use the two together, since they act at different points. Finasteride is also a medication, with its own side effects and contraindications; if you're interested, you can read about it in the article on DHT blockers.
If I don't respond to minoxidil, can microneedling help?
For some people minoxidil doesn't bring meaningful change, partly because their scalp has less of the enzyme that converts it into the active form. Suchonwanit 2019 The clinical study on the microneedling combination suggests that adding microneedling can help some people more than minoxidil alone. Dhurat 2013 This was studied with a 1.5 mm clinical roller; the Dermastamp is a fixed 1 mm, at-home device.
Can it be used on the beard or eyebrows?
Both are outside the official indication. Suchonwanit 2019 There are small, placebo-controlled studies on eyebrows, and the review judges eyebrow and beard use to be safe and beneficial. With one important difference: these studies used 1–3% minoxidil, not the 5% available at the pharmacy, and unwanted hair growth is most common precisely at the higher concentration. Suchonwanit 2019 Facial skin is more sensitive and irritates more easily; near the eyebrows, extra caution is needed because of the proximity to the eye: a small area, a small amount, and applied so it can't run into the eye. If you try it, keep in mind that after stopping, the hair gained there can shed too.
Can it give me unwanted facial hair?
It's possible, because the hair-growth effect doesn't stop at the scalp, and the chance of it rises with higher concentration. It helps to apply it only to the scalp, finish application by washing your hands, and avoid getting it on your face. If you notice bothersome hair growth, tell your doctor.
Can it cause heart palpitations or other systemic symptoms?
Rarely, heart palpitations, a fast pulse, or fluid retention can occur, more often with the oral form than with the scalp-applied one. If you experience this, stop and see a doctor. With existing heart or kidney disease, or low blood pressure, talk to a doctor before you even start.
Is minoxidil dangerous for cats or dogs?
Yes, and especially for cats. According to a veterinary case series, even a very small amount, a few drops or residue licked off the skin, can cause symptoms, and fatal poisoning has been documented in cats. Tater 2021 Wash your hands after application, keep the bottle locked away, and until the treated scalp has dried, don't let either the animal or a shared pillow touch it. If the animal does come into contact with it, call a vet immediately.
Can I use it right after microneedling?
The studied protocol didn't apply minoxidil on the day of treatment, resuming application 24 hours later. Dhurat 2013 It's not a good idea to apply an active ingredient right away to freshly punctured, sensitive skin, since it's absorbed more through the open microchannels. Set the exact order and timing according to the label.
Sources
These sources are about the mechanism of minoxidil and microneedling. The data on minoxidil comes from the pharmaceutical literature; the microneedling combination was studied with a 1.5 mm clinical roller under controlled conditions, not with an at-home 1 mm device.
- Patel P, Nessel TA, Kumar DD. Minoxidil. StatPearls. 2023. Bookshelf ID NBK482378 · PMID 29494000 · origin (vasodilator blood pressure drug), mechanism (potassium-channel opener, anagen extension), solution vs propylene-glycol-free foam, side effects, and the maintenance-dependent effect (long-term use is needed, the achieved state fades with discontinuation).
- Suchonwanit P, Thammarucha S, Leerunyakul K. Minoxidil and its use in hair disorders: a review. Drug Des Devel Ther. 2019. PMID 31496654 · PMC PMC6691938 · the effect via the minoxidil sulfate metabolite, extension of the anagen phase, foam tolerability, and the gradual shedding-back in the following months after stopping.
- Dhurat R, Sukesh M, Avhad G, et al. A Randomized Evaluator Blinded Study of Effect of Microneedling in Androgenetic Alopecia. Int J Trichology. 2013. PMID 23960389 · microneedling + minoxidil vs. minoxidil alone, with a clinical roller (1.5 mm), evaluator-blinded; the protocol skipped minoxidil on the day of treatment and resumed it 24 hours later.
- Physiological Mechanisms and Therapeutic Applications of Microneedling: A Narrative Review. Cureus. 2025. PMC PMC11993440 · the mechanism of microneedling: the repair response, growth factors, angiogenesis, and the temporarily increased permeability of the microchannels.
- NNGYK (formerly OGYÉI) medicines database and abbreviation list. Retrieved: 2026.07.26. medicines database · abbreviations · this is the source for REGAINE 2% (OGYI-T-02065), MINOXIDIL MIOWELL 5% (OGYI-T-24558), REVICAPIL 5% (OGYI-T-23828), and BRILLATON 5% (OGYI-T-24225) all being "VN," meaning available without a prescription, and for "TK" meaning a valid Hungarian marketing authorization.
- NNGYK/OGYÉI: Buying medication online. Published 2022.11.15. ogyei.gov.hu · this is the literal source for the fact that only pharmacies may sell medication online, that online orders are limited to non-prescription, non-reimbursed products, and that delivery is carried out by the pharmacy's professional staff.
- Directive 2011/62/EU of the European Parliament and of the Council on the prevention of falsified medicines, and Commission Implementing Regulation 699/2014/EU on the common logo. 2011/62/EU · 699/2014/EU · under Article 85c(1), the seller must be authorized to supply medicinal products to the public in its own member state, and the product must also comply with the law of the member state of destination; the logo is static, at least 90 pixels wide, and must contain a hyperlink to the official register.
- Commission Delegated Regulation (EU) 2016/161 on safety features. 2016/161/EU · under Article 45(2) and Annex II, of the non-prescription medications only omeprazole 20 mg and 40 mg carry a unique identifier, so non-prescription topical minoxidil doesn't have, and can't have, a 2D code; under Article 25, authenticity verification and decommissioning of the code is the task of the dispensing pharmacist, the patient is not among those authorized to do it.
- NNGYK: Dermatological use of minoxidil-based medications in androgenetic alopecia (off-label prescribing recommendation). Published 2025.11.12, case number NNGYK/84699-2/2025. ogyei.gov.hu · this is the source for the fact that dermatology specialists may prescribe it under a simplified procedure, and that in the attached table, oral minoxidil is listed as an individual-import product.
- U.S. FDA DailyMed: KIRKLAND SIGNATURE MINOXIDIL solution. dailymed.nlm.nih.gov · a 5% minoxidil solution marketed in the United States as a non-prescription medication (HUMAN OTC DRUG LABEL, ANDA075598); the absence of Hungarian authorization follows from the Hungarian medicines database, not from this source. Method of checking the absence: in the NNGYK medicines database's full product list (retrieved 2026.07.26), the name "Kirkland" does not appear, and the items with the active ingredient "minoxidil" are exclusively topical solutions.
- U.S. FDA: LONITEN (minoxidil) tablets, officially approved product information. accessdata.fda.gov · oral minoxidil is an approved product for severe high blood pressure; its use for hair loss falls outside its own indication. This is the source for the article's statement that it was originally a blood-pressure-lowering drug.
- NNGYK: Reporting a crime, medicine counterfeiting. Last modified: 2026.07.15. ogyei.gov.hu · verbatim: "The report can be made via the official gateway, or using the hamisgyogyszer@nngyk.gov.hu email address." This is the current reporting address; the older address ending in ogyei.gov.hu no longer appears on this page.
- Penha MA et al. Oral Minoxidil vs Topical Minoxidil for Male Androgenetic Alopecia: A Randomized Clinical Trial. JAMA Dermatol. 2024;160(6):600-605. PMID 38598226 · double-blind, with a placebo in both arms, 24 weeks, 90 enrolled and 68 completing participants; the closing finding, verbatim, is that 5 mg oral minoxidil "did not demonstrate superiority" over twice-daily 5% topical, and that in the oral arm unwanted hair growth occurred in 22 of 45 participants (49%). The limitation: Not a non-inferiority trial, and the number of completers is low.
- Sobral MVS et al. Efficacy and safety of oral minoxidil versus topical solution in androgenetic alopecia: a meta-analysis of randomized clinical trials. Int J Dermatol. 2025;64(3):479-484. PMID 39425514 · four randomized trials, 279 patients in total: there was no difference in either hair density or hair-shaft diameter, but unwanted hair growth was significantly more common in the oral group (relative risk 2.01). The limitation: "No difference" is not the same as "proven equivalent."
- Gupta AK et al. There Is a Positive Dose-Dependent Association between Low-Dose Oral Minoxidil and Its Efficacy for Androgenetic Alopecia: Findings from a Systematic Review with Meta-Regression Analyses. Skin Appendage Disord. 2022;8(5):355-361. PMID 36161084 · pooled analysis of six trials: a +1 mg daily dose increase over six months was associated with an average +47.1 hair per square centimeter increase in overall density, while also carrying a +17.9% unwanted-hair-growth risk and a +4.8% cardiovascular side-effect risk. The limitation: This is an association, not causal proof.
- Vañó-Galván S et al. Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. J Am Acad Dermatol. 2021;84(6):1644-1651. PMID 33639244 · the most common side effect was unwanted hair growth (15.1%); among systemic symptoms, dizziness (1.7%), fluid retention (1.3%), and rapid heartbeat (0.9%) occurred most often. 1.7% of patients discontinued treatment due to a side effect: 0.5% due to unwanted hair growth, 1.2% due to systemic symptoms. No life-threatening side effect was reported in the series.
- Chitalia J et al. Characterization of follicular minoxidil sulfotransferase activity in a cohort of pattern hair loss patients from the Indian Subcontinent. Dermatol Ther. 2018;31(6):e12688. PMID 30295395 · this is the source of the 40.8%, and in men 49.3%, figures. The limitation: The measurement was done on 120 hair-loss patients at a single centre in India, so it doesn't apply to the population as a whole, and there is no Hungarian data.
- Jimenez-Cauhe J et al. Hair follicle sulfotransferase activity and effectiveness of oral minoxidil in androgenetic alopecia. J Cosmet Dermatol. 2024;23(11):3767-3773. PMID 39034734 · 85% of patients with low scalp enzyme activity responded to oral minoxidil, versus 43% of those with high enzyme activity. The limitation: 41 people, no control group, full text is paywalled; the same research group previously wrote that follicular enzyme activity also predicts oral response, so the question isn't settled. The earlier work, starting from the genetic angle: Ramos PM, Gohad P, McCoy J, Wambier C, Goren A. J Eur Acad Dermatol Venereol. 2021;35(1):e24-e26 (SULT1A1 genetic variants and oral minoxidil response).
- European Medicines Agency and the coordination group of member states, minoxidil review (PSUSA/00002067/202310), 2024 · following this, the "Do not ingest." warning is mandatorily added to the packaging of topical minoxidil products, specifically because of the data available on accidental ingestion.
- Government Decree 448/2017. (XII. 27.) on authorizing the individual ordering and use of medicinal products for human use, and Section 25 of Act XCV of 2005 · individual medicine procurement is initiated with the authority by the treating doctor (not the patient); the administrative deadline is 8 working days, and in especially justified, urgent cases the request can also be submitted in another written form. The doctor hands a copy of the authority's statement to the patient, and this is what lets the product be dispensed at the pharmacy. The limitation: We found no provision in the decree about the product's reimbursement rules that we could state in the article, so we don't write about it.
- Act XCVIII of 2006 on the safe and economical supply of medicines and medical aids, amended by Section 19 of Act CXXIX of 2021 (in effect from 2022) · under this, medication cannot be dispensed by mail order, so obtaining a prescription-only product by post isn't a viable route even if the prescription comes from a foreign doctor. The limitation: We were unable to confirm the exact section location in two independent lookups, so we cite the provision by content, not verbatim. A pharmacy's own home delivery is a separate case from this.
- EüM Decree 43/2005. (X. 15.) · the often-mentioned 90-day quantity threshold applies to the personal import of strictly controlled substances, with certification from the authority of the country of origin. Minoxidil doesn't fall into this category, so this rule doesn't apply to it, and it doesn't override the mail-order ban either.
- Our own literature search for the combined use of oral minoxidil and microneedling, retrieved 2026.07.26 · PubMed (`oral minoxidil AND (microneedling OR dermaroller OR microneedle)`): 21 results, of which 0 examine the two together. Europe PMC ("oral minoxidil" AND "microneedling"): 66 results, of which 0. Without exception, the results study topical minoxidil with microneedling, or list the two as separate treatments. The query is reproducible.
- Tater KC, Gwaltney-Brant S, Wismer T. Topical Minoxidil Exposures and Toxicoses in Dogs and Cats: 211 Cases (2001-2019). J Am Anim Hosp Assoc. 2021. PMID 34370845 · veterinary case series: in cats and dogs, even a small amount of exposure (a drop, licking) caused symptoms, and fatalities occurred in cats.
- OGYÉI: Distribution of medications outside pharmacies. ogyei.gov.hu/patikan_kivuli_gyogyszerek · a store may only sell non-prescription medication specifically classified for this by the authority (under the conditions of Annex 4 of EüM Decree 52/2005. (XI. 18.)); in the official abbreviation list, its mark is "GYK – can be distributed outside pharmacies." On the data sheets of minoxidil products, the dispensing status is "VN" without the GYK mark.


